A flowering shrub from the Andean cloud forests made taxonomic history last month. The plant—now dubbed Brunfelsia plowmaniana—had puzzled botanists for decades as they endeavored to determine whether or not it was truly an evolutionary newcomer. When its DNA revealed this to be true, researchers made the unprecedented move to include B. plowmaniana’s genetic code in its description as a new species, in the journal PhytoKeys. That decision could open the door to future DNA definitions of new botanical species—and heal a rift in the field of botany.
B. plowmaniana’s saga began 30 years ago, when botanist Michael Nee approached ethnobotanist Timothy Plowman at The Field Museum in Chicago with specimens from a flowering shrub collected in the Bolivian mountains. A member of the nightshade family, Brunfelsia are known for their occasionally toxic and hallucinogenic properties, as well as their bright, color-changing flowers.
The particular species Nee presented to Plowman was labeled Brunfelsia uniflora—however, Nee and Plowman questioned the identification. Plowman had studied B. uniflora in the Brazilian lowlands, and it seemed improbable that the same plant had dispersed hundreds of kilometers into the cloud forests. Yet neither botanist was certain: “Plowman didn’t know this specimen as a living plant, and I didn’t know the Brazilian plant as a living plant,” says Nee, now a botanist at The New York Botanical Garden. Convinced of a difference but unable to pinpoint it, Plowman continued to study and revise his writings on the brunfelsia genus until his death in 1989, yet he never solved the riddle.
More than two decades later, molecular biologist Natalia Filipowicz at the Munich Botanical Garden’s herbarium reexamined the mysterious shrub. Filipowicz studied specimens from 50 species of Brunfelsia to characterize the genetic variation across the genus. When she reached the presumed B. uniflora of the Andes, she hit upon a set of genes that confirmed Plowman and Nee’s suspicions. “Simply put,” Filipowicz says, “the new species had unique DNA substitutions in the region that we studied.” The substitutions proved that this Brunfelsia species was unique. Filipowicz and botanist Susanne Renner, director of the Ludwig Maximilians University of Munich Herbarium and Munich Botanical Garden, turned to Nee for a new physical description of the plant, and the trio published their description of Brunfelsia plowmaniana, named in honor of Timothy Plowman.
Including Filipowicz’s genomic analysis prominently might seem like a logical choice, yet, despite dozens of other species confirmed in a similar manner, their description was a first.
In fact, in 1996, the International Botanical Congress (IBC), which determines the code for naming new species, had roundly rebuffed an effort to publish species identification based primarily on genetic analysis. The reaction discouraged many in the field from similar efforts for years.
Why has the acceptance of molecular evidence taken so long? The delay is due in part to a long existing cultural divide in botany: On one side are botanists who work in the field and herbarium (storehouses for dried plants).
On the other are those in the laboratory who put plants under the microscope or examine their chemical makeup. Although crossover does exist, increasing specialization has disproportionately given the task of naming a new species to the former group.
“Traditionally, the people who work in the herbarium and name the plants never set foot in the lab— and the people in the lab are typically not the ones who name plants because they don’t know how to and the rules are so arcane,” Renner says.
FROM | www.scientificamerican.com
Antarctica is one of the most pristine environments on Earth, but it’s wrestling with a pollution problem. And the very people who are working hardest to protect the continent are responsible. Read More
The heat from warm river waters draining into the Arctic Ocean is contributing to the melting of Arctic sea ice each summer, a new NASA study finds Read More
Canada’s lack of progress in regulating veterinary use of antibiotic drugs has been called “a continuing international and national embarrassment” in light of dire warnings about the growing danger of drug resistance, says a report in the Canadian Veterinary Journal. Read More